Extended observations on MS patients treated with IM interferon-β1a (Avonex™): implications for modern MS trials and therapeutics
Lawrence Jacobs, Richard Rudick, Jack SimonVolume:
107
Year:
2000
Language:
english
Pages:
7
DOI:
10.1016/s0165-5728(00)00232-0
File:
PDF, 82 KB
english, 2000